These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease. Maximos M, Bril F, Portillo Sanchez P, Lomonaco R, Orsak B, Biernacki D, Suman A, Weber M, Cusi K. Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475 [Abstract] [Full Text] [Related]
10. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Goodman Z, Younossi ZM. Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462 [Abstract] [Full Text] [Related]
11. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index. Wang Z, Xu M, Hu Z, Shrestha UK. Menopause; 2015 Jun; 22(6):667-73. PubMed ID: 25513983 [Abstract] [Full Text] [Related]
19. Combination of Aspartate Aminotranferase and Tumor Necrosis Factor-α as Non Invasive Diagnostic Tools for Non Alcoholic Steatohepatitis (NASH). Purnomo HD, Mundhofir FE, Kasno, Sudijanto E, Darmono, Daldiyono, Djokomoeljanto R, Faradz SM. Acta Med Indones; 2015 Jan; 47(1):16-23. PubMed ID: 25948763 [Abstract] [Full Text] [Related]